Orano Med Employee Directory
Biotechnology ResearchÎle-de-France, France201-500 Employees
Orano Med is a biotechnology research company focused on nuclear medicine. Building on an R&D program begun in 2005, it has developed processes to produce high-purity lead-212, a rare radioactive isotope used in targeted alpha therapies to destroy cancer cells with limited impact on neighboring healthy tissue. The organization operates within the Orano group and includes Macrocyclics, Inc., a global leader in chelating agent technology. Based in the Île-de-France region near Paris, Orano Med announced an expansion of its facilities to Villejuif in May 2026, establishing its global headquarters and enhanced R&D laboratories. It has engaged in collaborations with Roche to develop a therapeutic solution targeting the carcinoembryonic antigen, reflecting its activity in oncology radiopharmaceuticals.
1-888-653-2347 
support@leadiq.com 
